Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs
Mohsen Hosseini(Princess Margaret Cancer Centre), Steven M. Chan(Princess Margaret Cancer Centre), Martina Fiumara(The San Raffaele Telethon Institute for Gene Therapy), Gary D. Bader(University of Toronto), Séverine Cathelin(Princess Margaret Cancer Centre), Véronique Voisin(University of Toronto), Julie A. Reisz(University of Colorado Anschutz Medical Campus), Samuele Ferrari(Vita-Salute San Raffaele University), Angelica Varesi(The San Raffaele Telethon Institute for Gene Therapy), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Aaron D. Schimmer(University of Toronto), Alex C.H. Liu(University of Toronto), Kira Young(Jackson Laboratory), Stephanie Z. Xie(Princess Margaret Cancer Centre), Jennifer J. Trowbridge(Jackson Laboratory), Luigi Naldini(Vita-Salute San Raffaele University), Dhanoop Manikoth Ayyathan(Princess Margaret Cancer Centre), Federico Gaiti(University of Toronto), John E. Dick(University of Toronto), Ali Chegini(University of Toronto), Shraddha Pai(Ontario Institute for Cancer Research), Yiyan Wu(University of Toronto), Yitong Yang, Vivian Wang(University of Toronto), Éric Grignano(Centre National de la Recherche Scientifique), Abdula Maher(Princess Margaret Cancer Centre), Grace Egan(Hospital for Sick Children)
Cited by 43
Related Papers
Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.
|Proceedings of the National Academy of Sciences|1996|1.5k